Device Trial Radar · NCT07035288
PulseSelect Based Pulmonary Vein Isolation and Ablation in Patients With Atrial Fibrillation
Last checked: Nov 20, 2026Latest source record: Sep 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Nov 1, 2024
Primary completion
Jun 30, 2025
Study completion Jul 10, 2025
Sponsor
- Lead sponsor
- Tsiachris DimitriosAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medtronic Atrial Fibrillation Solutions
- First posted
- Jun 25, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Electroanatomical mapping (EAM) based pulmonary vein isolation (PVI) by means of PulseSelect catheter and deep sedation will be compared to fluoroscopy based pulmonary vein isolation in patients with atrial fibrillation in the acute and long term (2 months remapping).
Conditions
- Atrial Fibrillation (AF)
- Catheter Ablation
- Pulmonary Vein Isolation
Interventions
EAM based Pulmonary Vein IsolationDevice
20 patients with symptomatic paroxysmal or persistent AF will be scheduled for pulmonary vein isolation (PVI) based to EAM by means of the PulseSelect catheter. Ablation will be performed in a deep sedation setting and additional ablation within the pulmonary veins will be assessed
Fluoro based pulmonary vein ablationDevice
20 patients with symptomatic paroxysmal or persistent AF will be scheduled for pulmonary vein isolation (PVI) based to Fluoroscopy by means of the PulseSelect catheter. Ablation will be performed in a deep sedation setting and additional ablation within the pulmonary veins will be assessed
Primary outcomes
What the sponsor says the trial is designed to measure.
- Durability of PVITime frame: 2 to 3 months post index ablation
- PVI durability by means of a fluoroscopy-based or an EAM-based index procedureTime frame: 2 to 3 months post index ablation
- Identification of pulmonary vein isolation gaps acutely based on EAMTime frame: 2 to 3 months post index ablation
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
First Department of Cardiology, National and Kapodistrian University of Athens, Hippokration General Hospital
Athens, Attica, Greece
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.